Ethical aspects of registry-based research in the Nordic countries

Clinical Epidemiology

Volumn 7, Issue , 2015, Pages 491-508

  Ludvigsson, Jonas F ^a,b   Håberg, Siri E ^c   Knudsen, Gun Peggy ^c   Lafolie, Pierre ^a   Zoega, Helga ^d   Sarkkola, Catharina ^e   von Kraemer, Stephanie ^e   Weiderpass, Elisabete ^a,e,f,g   Nørgaard, Mette ^h  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF ICELAND   (Iceland)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f UNIVERSITY OF TROMSØ   (Norway)

^g The Arctic University of Norway ^*  (Norway)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ethical review; Ethics; Informed consent; Institutional review board; Nordic countries; Registry based research

Indexed keywords

CHILD; DENMARK; ETHICS; FINLAND; GOVERNMENT; HUMAN; HUMAN EXPERIMENT; ICELAND; INFORMED CONSENT; NORWAY; REGISTER; SWEDEN;

EID: 84948972469     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S90589     Document Type: Review

References (76)

1. Anell A. The public-private pendulum - patient choice and equity in Sweden. N Engl J Med. 2015;372(1):1-4.
2. Kettis-Lindblad A, Ring L, Viberth E, Hansson MG. Perceptions of potential donors in the Swedish public towards information and consent procedures in relation to use of human tissue samples in biobanks: a population-based study. Scand J Public Health. 2007;35(2):148-156.
3. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8): 541-549.
4. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659-667.
5. Hemminki K, Li X, Sundquist J, Sundquist K. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia. 2009;52(9):1820-1828.
6. Skjaerven R, Vatten LJ, Wilcox AJ, Rønning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331(7521):877.
7. Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124(25):2839-2846.
8. Bakken IJ, Revdal E, Nesvåg R, et al. Substance use disorders and psychotic disorders in epilepsy: a population-based registry study. Epilepsy Res. 2014;108(8):1435-1443.
9. Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368(4):333-340.
10. Centrala etikprövningsnämnden - Central ethical review board annual report 2014 [homepage on the Internet]. Available from: http://www.epn.se/media/2100/cepns-aarsredovisning-2014.pdf. Accessed October 15, 2015.
11. Centrala etikprövningsnämnden - Central ethical review board - supervision. [homepage on the Internet]. Available from: http://www.epn.se/centrala-etikproevningsnaemnden/cepns-tillsyn/. Accessed October 15, 2015.
12. Finnish National Committee on Medical Research Ethics [webpage on the Internet]. Helsinki, Finland: Finnish National Committee on Medical Research Ethics; 2015. Available from: http://tukija.fi/en. Accessed September 25, 2015.
13. Vísindasiðanefnd (Bioethics) [homepage on the Internet]. Available from: www.vsn.is. Accessed October 15, 2015.
14. US department of Health & Human Services: Institution Review Boards [homepage on the Internet]. Available from: http://www.hhs.gov/ohrp/assurances/irb. Accessed October 15, 2015.
15. Lag om etikprövning av forskning som avser människor. Law about ethical review in human research. [homepage on the Internet]. Available from: http://www.riksdagen.se/sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Lag-2003460-om-etikprovning_sfs-2003-460/. Accessed October 15, 2015.
16. The Hospital District of Helsinki and Uusimaa [webpage on the Internet]. Finnish ethics application. Helsinki, Finland: The Hospital District of Helsinki and Uusimaa; 2015. Available from: http://www.hus.fi/tutkijalle/eettiset-toimikunnat/ohjeet-ja-hakemuslomakkeet/Sivut/default.aspx. Accessed May 22, 2015. Finnish.
17. Vísindasiðanefnd (Bioethics) - License for ethical approval [webpage on the Internet]. Available from: http://www.vsn.is/is/content/leyfisskylda. Accessed October 15, 2015.
18. Danish ethical review board. Guidelines about Notification etc. of a Biomedical Research Project to the Committee System on Biomedical Research Ethics, No 9154, 5 May 2011 [webpage on the Internet]. Available from: http://www.dnvk.dk/English/guidelinesaboutnotification.aspx#AFSNIT 2.0. Accessed October 15,2015.
19. Etikprövningsnämnderna. Ethical review boards. Application [webpage on the Internet]. Available from: http://www.epn.se/start/ansoekan/. Accessed October 15, 2015.
20. Swedish ethical review boards: Application form [webpage on the Internet]. Available from: www.epn.se/media/1023/ansoekningsblankett.doc. Accessed October 15, 2015.
21. Trevena L, Irwig L, Barratt A. Impact of privacy legislation on the number and characteristics of people who are recruited for research: a randomised controlled trial. J Med Ethics. 2006;32(8):473-477.
22. Woolf SH, Rothemich SF, Johnson RE, Marsland DW. Selection bias from requiring patients to give consent to examine data for health services research. Arch Fam Med.2000;9(10):1111-1118.
23. Junghans C, Feder G, Hemingway H, Timmis A, Jones M. Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies. BMJ. 2005;331(7522):940.
24. Crombie IK, McMurdo ME, Irvine L, Williams B. Overcoming barriers to recruitment in health research: concerns of potential participants need to be dealt with. BMJ. 2006;333(7564):398.
25. Hewison J, Haines A. Overcoming barriers to recruitment in health research. BMJ. 2006;333(7562):300-302.
26. Swedish ethical review boards: Application form [webpage on the Internet]. Available from: www.epn.se/media/1023/ansoekningsblankett.doc. Accessed October 15, 2015.
27. World Health Organization Research Ethics Review Committee [webpage on the Internet]. The Process of Obtaining Informed Consent. Geneva, Switzerland: World Health Organization; 2015. Available from: http://www.who.int/rpc/research_ethics/Process_seeking_IF_printing.pdf. Accessed May 25, 2015.
28. Kho ME, Duffett M, Willison DJ, Cook DJ, Brouwers MC. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ. 2009;338:b866.
29. Swedish ethical review boards: Application form [webpage on the Internet]. Available from: www.epn.se/media/1023/ansoekningsblankett.doc. Accessed October 15, 2015.
30. The Swedish data inspection board: The personal data act [webpage on the Internet]. Available from: http://www.datainspektionen.se/in-english/legislation/the-personal-data-act/. Accessed October 15, 2015.
31. Datatilsynet. The Danish data inspection board: Compiled version of the act on processing of personal data [webpage on the Internet]. Available from: http:///www.datatilsynet.dk/english/the-act-on-processing-of-personal-data/read-the-act-on-processing-of-personal-data/compiled-version-of-the-act-on-processing-of-personal-data/. Accessed October 15, 2015.
32. The Icelandic Data Protection Act [webpage on the Internet]. Available from: http://www.personuvernd.is/information-in-english/greinar/nr/438. Accessed October 15, 2015.
33. Joint Nordic Registers and Biobanks - a goldmine for health and welfare research [webpage on the Internet]. Available from: http://www.nordforsk.org/en/publications/publications_container/joint-nordic-registers-and-biobanks-a-goldmine-for-health-and-welfare-research. Accessed October 15, 2015.
34. Silverman HJ, Druml C, Lemaire F, Nelson R; European Union Directive. The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis. Intensive Care Med. 2004;30(9):1723-1729.
35. Liddell K, Bion J, Chamberlain D, et al. Medical research involving incapacitated adults: implications of the EU Clinical Trials Directive 2001/20/EC. Med Law Rev. 2006;14(3):367-417.
36. Gysels MH, Evans C, Higginson IJ. Patient, caregiver, health professional and researcher views and experiences of participating in research at the end of life: a critical interpretive synthesis of the literature. BMC Med Res Methodol. 2012;12:123.
37. [No authors listed]. Looking back on the millennium in medicine. N Engl J Med. 2000;342(1):42-49.
38. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682):739-748.
39. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J. 1954;1(4877):1451-1455.
40. Nordforsk [homepage on the Internet]. Available from: http://www.nordforsk.org. Accessed October 15, 2015.
41. Nordic Trial Alliance [homepage on the Internet]. Oslo, Norway: The Nordic Council of Ministers and NordForsk; 2015. Available from: http://nta.nordforsk.org. Accessed October 5, 2015.
42. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78-85.
43. Furu K, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798.
44. Stephansson O, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA. 2013;309(1):48-54.
45. Sandin S, Schendel D, Magnusson P, et al. Autism risk associated with parental age and with increasing difference in age between the parents. Mol Psychiatry. Epub 2015 Jun 9.
46. Nyrén O, Stenbeck M, Grönberg H. The European Parliament proposal for the new EU General Data Protection Regulation may severely restrict European epidemiological research. Eur J Epidemiol. 2014;29(4):227-230.
47. Gillon R. Medical ethics: four principles plus attention to scope. BMJ. 1994;309(6948):184-188.
48. Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish Healthcare Quality Registries. J Intern Med. 2015;277(1):94-136.
49. Van Hemelrijck M, Wigertz A, Sandin F, et al; NPCR and PCBaSe Sweden. Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol. 2013;42(4):956-967.
50. Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2): 111-122.
51. Larsson SC, Wolk A. Dietary fiber intake is inversely associated with stroke incidence in healthy Swedish adults. J Nutr. 2014;144(12): 1952-1955.
52. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84(3):399-404.
53. Naess O, Stoltenberg C, Hoff DA, et al. Cardiovascular mortality in relation to birth weight of children and grandchildren in 500,000 Norwegian families. Eur Heart J. 2013;34(44):3427-3436.
54. Granlund J, Svensson T, Granath F, et al. Diverticular disease and the risk of colon cancer - a population-based case-control study. Aliment Pharmacol Ther. 2011;34(6):675-681.
55. Cantarutti A, Bonn SE, Adami HO, Grönberg H, Bellocco R, Bälter K. Body mass index and mortality in men with prostate cancer. Prostate. 2015;75(11):1129-1136.
56. Holm M, Olsen A, Christensen J, et al. Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: results from a prospective cohort with a wide range of variation in alcohol intake. Int J Cancer. 2013;132(3):686-694.
57. Kristinsson SY, Eloranta S, Dickman PW, et al. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Am J Hematol. 2013;88(1):60-65.
58. Román M, Sakshaug S, Graff-Iversen S, et al. Postmenopausal hormone therapy and the risk of breast cancer in Norway. Int J Cancer. Epub 2015 Aug 20.
59. Lichtenstein P, Halldner L, Zetterqvist J, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367(21):2006-2014.
60. Madsen KB, Ersbøll AK, Olsen J, Parner E, Obel C. Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study. Int J Health Geogr. 2015;14(1):24.
61. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363(22):2114-2123.
62. Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M. Prescription drug use among pregnant women in opioid maintenance treatment. Addiction. 2013;108(2):367-376.
63. Vestergaard AH, Christiansen CF, Nielsen H, Christensen S, Johnsen SP. Geographical variation in use of intensive care: a nationwide study. Intensive Care Med. Epub 2015 Aug 4.
64. Kristiansen NS, Mainz J, Nørgård BM, Bartels PD, Andersen G, Johnsen SP. Off-hours admission and acute stroke care quality: a nationwide study of performance measures and case-fatality. Stroke. 2014;45(12):3663-3669.
65. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
66. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45(3):320-323.
67. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull. 1997;44(5):535-539.
68. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42-45.
69. Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997;44(1):82-84.
70. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
71. de Faire U, Friberg L, Lorich U, Lundman T. A validation of cause-of-death certification in 1,156 deaths. Acta Med Scand. 1976;200(3):223-228.
72. Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol. 2000;29(3):495-502.
73. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
74. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305-313.
75. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726-735.
76. World Health Organization. International classification of diseases for oncology (ICD-O): Third edition, First revision. Geneva: World Health Organization; 2013. Available from: http://apps.who.int/iris/bitstream/10665/96612/1/9789241548496_eng.pdf?ua=2. Accessed September 29, 2015.